SEC Form 4 research
| Issuer | Candel Therapeutics, Inc. |
|---|---|
| Tickers | CADL |
| Reporting owners | 25 |
| Officers and directors | 11 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | Loggia Nicoletta | A | 380 | $8.68 | Not reported |
| 2026-10-02 | 2026-09-30 | PAPA JOSEPH C | A | 1,325 | $8.68 | Not reported |
| 2026-10-02 | 2026-09-30 | Manning Paul B | A | 2,189 | $8.68 | Not reported |
| 2026-09-11 | 2026-09-11 | Tak Paul Peter | S | 59,379 | $10.46 | Not reported |
| 2026-09-11 | 2026-09-10 | Tak Paul Peter | S | 220,866 | $11.5 | Not reported |
| 2026-09-10 | 2026-09-08 | Zimmermann Martine | A | 64,000 | $0 | Not reported |
| 2026-08-19 | 2026-08-17 | Tyagarajan Seshu | S | 7,000 | $12 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.